ATH 33.3% 0.4¢ alterity therapeutics limited

imagine extension trial proceeds, page-2

  1. 3,401 Posts.
    lightbulb Created with Sketch. 72
    83% opted for pbt2 and further brain scans, blood tests and cognitive testing, not bad take up imo
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.